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Abstract
After oral exposure, prions are thought to enter Peyer’s patches via M cells and accumulate first upon follicular dendritic
cells (FDCs) before spreading to the nervous system. How prions are actually initially acquired from the gut lumen is not
known. Using high-resolution immunofluorescence and cryo-immunogold electron microscopy, we report the trafficking of
the prion protein (PrP) toward Peyer’s patches of wild-type and PrP-deficient mice. PrP was transiently detectable at 1 day
post feeding (dpf) within large multivesicular LAMP1-positive endosomes of enterocytes in the follicle-associated epithelium
(FAE) and at much lower levels within M cells. Subsequently, PrP was detected on vesicles in the late endosomal
compartments of macrophages in the subepithelial dome. At 7–21 dpf, increased PrP labelling was observed on the plasma
membranes of FDCs in germinal centres of Peyer’s patches from wild-type mice only, identifying FDCs as the first sites of PrP
conversion and replication. Detection of PrP on extracellular vesicles displaying FAE enterocyte-derived A33 protein implied
transport towards FDCs in association with FAE-derived vesicles. By 21 dpf, PrP was observed on the plasma membranes of
neurons within neighbouring myenteric plexi. Together, these data identify a novel potential M cell-independent
mechanism for prion transport, mediated by FAE enterocytes, which acts to initiate conversion and replication upon FDCs
and subsequent infection of enteric nerves.
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Introduction
Prions are infectious proteins composed of an abnormally folded
isoform of the prion protein (PrPSc), the accumulation of which
causes variant Creutzfeldt–Jakob disease, scrapie, and bovine
spongiform encephalopathy, among other diseases. Prions prop-
agate by converting endogenous, cellular prion protein (PrPC) into
PrPSc containing a b-sheet core. Isolated PrPSc can be found in a
wide range of aggregation states, from small oligomers to amyloid,
and at least in larger aggregates the C-terminal portion of PrPSc
acquires resistance to protease treatment [1]. PrPC is a
ubiquitously expressed protein that is most abundant in the
nervous system. The accumulation of PrPSc causes morphological
changes in the central nervous system including astrocytosis,
neuronal cell loss and spongiform pathology and, in some types of
prion disease, amyloid plaque formation. Pathology builds up
during a long incubation period that ends in a short clinical phase
and death. Expression of PrPC in the host is required for successful
infection, since it provides the substrate for the conversion to PrPSc
[2–5].
Prions are highly resistant to denaturation by chemical and
physical means, making disposal and disinfection difficult. This
resistance may also contribute to their ability to survive passage
through the digestive tract [6], allowing transmission of prion
disease via prion-contaminated food. Many naturally occurring
prion diseases are considered to be acquired orally, and are
accompanied by accumulation of PrPSc in the lymphoreticular
system long before invasion of the nervous system takes place [7–
13]. Indeed, when specific components of the gut-associated
lymphoid tissues (GALT) are absent, the transport of prions from
the gut lumen to the nervous system is dramatically impaired
[9,12,14]. The exact mechanisms by which infectious prions are
transmitted from the gut lumen to the central nervous system
remain elusive (for reviews see [15–17]).
The luminal surface of the intestine limits the access of
pathogenic microorganisms to the underlying host tissues, and is
protected by a single layer of epithelial cells bound by tight-
junctions. Located within the villus epithelium and follicle-
associated epithelium (FAE) of the Peyer’s patch are microfold
cells (M cells), a unique epithelial cell type specialized for the
transepithelial transport of macromolecules and particles (for a
review of M cells see [18]). M cells enable the host’s immune
system to sample the intestinal lumen and mount an appropriate
immune response. However, some pathogenic microorganisms
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exploit M cells and use them to gain entry into mucosal tissues
[18]. Using an in vitro system, M cell-like cells have been shown to
actively transcytose the scrapie agent through to the basolateral
side of the epithelium [19,20], and studies in mice suggest prions
might likewise be translocated across the FAE by M cells in vivo
[21].
Together these data imply that M cells are plausible sites for the
transepithelial transport of TSE agents across the intestinal
epithelium. However, other data suggest such transport might
also occur independently of M cell-mediated transcytosis via
enterocytes [22,23]. Studies in which isolated sheep gut loops were
injected with scrapie brain homogenate [22] suggested that
disease-specific PrP was transported across the absorptive
epithelium of villi into lacteals. Other studies have shown that in
response to inflammatory stimuli, mononuclear phagocytes within
the lamina propria, including macrophages and classical dendritic
cells (DC), can insert dendrites through the tight junctions between
intestinal epithelial cells. These projections enable the cells to
sample the luminal contents directly [24] implying another
potential route of transepithelial TSE agent transport. Clearly,
the way that orally introduced, partially proteinase-resistant prions
survive the proteolytic conditions in the alimentary tract without
losing all their infectivity and then cross the gut epithelium is still a
matter of debate.
After passing the epithelial barrier, prions are thought to be
captured by underlying migratory classical dendritic cells [25] that
transmit the infectious agents by an as-of-yet unknown mechanism
to the germinal centres. Within the germinal centres, prions
accumulate upon follicular dendritic cells (FDCs), which are
specialized stromal, mesenchymal cells of the immune system.
FDCs are nonphagocytic, nonmigratory cells that trap native
immune complexes on their surface through the expression of
cellular complement receptors. The expression of high levels of
PrPC in FDCs is regarded to be important for the accumulation
and replication of prions upon their surfaces [26–30].
FDCs are considered to amplify the prions above the threshold
level necessary to infect peripheral nerves [9,12,14,31]. Prions are
then thought to gain access to the central nervous system via
physical interaction with peripheral nerve fibers of the enteric
nervous system [32]. Retrograde axonal transport would deliver
prions to their main pathological target, the brain. Due to the lack
of satisfactory experimental models, some of the observations in
prion transmission are based solely on in vitro studies.
Here, we examined the in vivo time-course of oral prion infection
in the GALT of wild-type (wt) mice that are susceptible to prion
infection and of PrP-deficient (Prnp–/–) mice that do not succumb
to prion disease [33]. Both wt and Prnp–/– mice were orally
infected with 3 different rodent-adapted scrapie strains (ME7,
RML and Sc327), and intestinal and lymphoid tissues collected at
specific days post-feeding (dpf). Samples were then analysed by
immunofluorescence (IF) and cryo-immunogold electron micros-
copy (cryo-immuno EM) in order to identify, at the ultrastructural
level, the cell types and subcellular organelles that are involved in
prion trafficking and early pathogenesis. Our data show that prion
uptake and transfer across the follicle-associated epithelium (FAE)
of the gut occurred of the follicle-associated epithelium (FAE)
independently of cellular PrPC expression. We show that PrP was
first transiently detectable mainly within large LAMP1-positive
endosomes of FAE enterocytes and at much lower levels within M
cells. Proteins of FAE enterocytes were found on vesicles in the
extracellular material adjacent to FAE enterocytes, and on the
surface of FDCs, and these vesicles could act to transport prions
towards FDCs. Furthermore, between 7–21 dpf, increased PrP
labelling was only observed on the plasma membranes of FDCs
from wild-type mice, identifying these membranes as the first site
of PrP conversion and replication within Peyer’s patches.
Together, these data identify a novel potential M cell-independent
route of prion uptake and transfer from the gut lumen mediated by
FAE enterocytes that may have an important influence on
susceptibility to oral prion infection.
Results
Enterocytes within the FAE contain unique large apical
LAMP1-positive endosomes
In orally infected animals, prions are suspected to enter the
lymphoid and nervous systems from the intestine through the
FAE-overlying follicles of the mucosa-associated lymphoid tissue
[15–17]. Thus, we examined the FAE and subepithelial dome
(SED) region of Peyer’s patches in wild-type (wt) uninfected mice
and in wt mice infected with ME7 or RML prions. For
comparison we also examined normal villi in prion-infected and
uninfected mice. Late endocytic compartments were identified
using antibodies against LAMP1, a membrane protein specific for
these compartments (for an overview, see Figure 1A). By
immunofluorescence (IF) analysis, we found significantly larger,
LAMP1-positive endosomes with a typical multivesicular body
phenotype in the FAE as compared to those in neighbouring villi
(Figure 1B, 1D and Figure S1). Large LAMP1-positive endosomes
were also observed in macrophages in the SED region, but had
different more pleiomorphic morphology and stained less
intensively with LAMP1-antibody (Figure 2A, Figure S1). Large
LAMP1 endosomes of FAE enterocytes were abundant, had a
more regular round shape (appeared as ring-like structures in IF
and histochemistry sections) and had predominantly an apical
location between the nucleus and brush border. Occasionally,
when macrophages invade into the FAE their LAMP1 positive
endosomes retain their pleiomorphic morphology and are mostly
located basolaterally between the enterocyte nucleus and the basal
membrane (see Figure S1C). At EM level investigating the cellular
contours of individual cells by following their plasma membranes it
could be confirmed that the apical large LAMP1 positive
endosomes were located in FAE enterocytes and not for example
in FAE-invading macrophages (Figure S1). Similar observations
were made in both prion-infected and uninfected wt mice (data
not shown). These data suggest that FAE enterocytes could play an
important role in transcytosing partially digested, gut-derived
proteins to macrophages within the SED. The apical large
LAMP1 positive endosomes of FAE enterocytes were so distinctive
that their presence could be used as a useful landmark for
detecting the FAE in IF and EM sections.
Author Summary
Prion diseases are orally transmissible, but how the
abnormally folded isoform of the prion protein (PrPSc)
transits from the gastrointestinal tract to infect neural
tissues is not known. Here we demonstrate that in contrast
to the current literature, PrPSc enters Peyer’s patches
primarily through specialised enterocytes with much lower
levels trafficking through M cells. Proteins from homoge-
nized PrPSc infected brain tissue are transcytosed across
the follicle-associated epithelium and delivered to macro-
phages and follicular dendritic cells, which appear to serve
as the primary site of PrP conversion and replication
following oral exposure to PrPSc before infecting the
enteric nerves.
Subcellular Trafficking of Prions in the Gut
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Epithelial M cells (or microfold cells) within FAE are considered
as an entry point for many intestinal pathogens, both bacteria and
viruses [18] and also proposed as portals of entry for prions [19–21].
We identified M cells in the FAE using Ulex europaeus agglutinin 1
(UEA-1) as a marker. As anticipated, UEA-1 bound strongly to the
brush borders of M cells and to a lesser extent to their basolateral
cell membranes and the limiting membranes of intracellular vesicles
(Figure 1 C and D). The UEA-1 label was restricted to M cells in the
FAE and not observed in the neighbouring villus (Figure 1E,
although especially the mucus containing granules of goblet cells
elsewhere in the villi were often UEA-1 positive. Occasional goblet
cells could also be seen in the FAE, but were easily distinguished
from the UEA-1 positive M cells by their distinct morphology. The
identification of M cells in the FAE was further confirmed by using
antibodies specific to the M cell markers GP-2 [34] and annexin V
[35] see Figure S2. Cryo-immuno- EM revealed that UEA-1 -
positive cells within the FAE had typical, short, irregular microvilli
(Figure 1F and 1G, Figure S2 and S3) and often harboured
lymphocytes within an intracellular pocket. Each of these
observations is an established characteristic of M cells. Our analysis
revealed that M cells had smaller, LAMP1-positive late endosomes
and completely lacked the large late endosomes found in FAE
enterocytes. Few UEA-1 positive goblet cells were seen in the FAE
by EM, but were easily distinguished from M cells by their apical
mucus-containing granules and pronounced ER, typical for
secretory cells (see Figure S2).
Enterocytes within the FAE take up neurofilaments from
orally-acquired brain homogenate
Next, groups of PrP-expressing wt mice and PrP-deficient
(Prnp-/- mice) were orally exposed to prions, by feeding brain
homogenates from prion-infected mice. As controls, mice were fed
uninfected brain homogenate. In order to trace the fate of the
brain inoculum Peyer’s patches were collected at intervals after
exposure, and the early cellular and subcellular localization of
brain homogenate-derived neurofilaments (NF) determined by IF.
Peyer’s patches were also examined from age-matched mice that
had not been fed brain homogenate. Both wt and Prnp-/- mice fed
either prion-infected or uninfected brain homogenate showed
positive immunolabeling for NF, whereas untreated control mice
Figure 1. Follicle-associated epithelium (FAE) harbours enterocytes that have large apical late endosomal compartments and M
cells. Peyer’s patches were collected from wild-type 29/Ola mice 1 day after infection with ME7 prions. (A) Cellular organization of a Peyer’s patch
showing the LAMP1-positive compartments at the FAE and SED. (B) FAE enterocytes have large LAMP1-positive endosomes compared to enterocytes
in the villi. (C and D) UEA-1 positive (red) M cells within the FAE. Note in (D) the large apical LAMP1+ endosomes are not present in M cells, but only in
adjacent FAE enterocytes (arrowheads). N depicts the approximate location of nucleus in the epithelium (E) UEA-1 label is present only on FAE,
whereas the neighbouring villus is negative. IgG (green) presents the endogenous mouse IgGs. (F and G) Cryo-immuno EM reveals that M cells in the
FAE differ from enterocytes by having irregular microvilli that are UEA-1–positive (F, G). The diameter of the UEA-1–specific gold particles in (F) and
(G) is 15 nm. Note in (F) the arrow points to a PrP-positive early endosomal vesicle in the UEA-1 negative enterocyte, whereas little PrP uptake is
detectable in the UEA-1 positive M cell. PrP was detected with PrP-specific 6H4 monoclonal antibody directly conjugated to UltraSmall gold (PrP-usg)
and visualized by silver enhancement. A larger high resolution version of Figure 1F is provided as a supplement (Figure S3). SED, subepithelial dome;
GC, germinal centre; V, villus; M, M cells; E, enterocytes. Scale bars: (A) 80 mm; (B) 15 mm; (C) 10 mm; (D) 15 mm; (E) 20 mm; (F) 200 nm and (G) 200 nm.
doi:10.1371/journal.ppat.1002449.g001
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were negative for NF immunolabeling (data not shown). In Peyer’s
patches taken at 1 dpf, NFs were detected in FAE enterocytes
within the large LAMP1-positive endosomes of mice exposed to
prion and normal brain homogenate (Figure 2A, 3A). Both wt and
Prnp–/– mice showed similar levels of NF staining in FAE
enterocytes, indicating that the uptake of NF was not dependent
on PrPC expression (Figure 3A). Much fewer NF-positive
endosomes or other NF-containing organelles were found within
M cells in the FAE of Peyer’s patches from the prion-exposed or
control animals (Figure 3A). By immunogold-EM the prion
inoculum was locally visible in the lumen of the gut (Figure 2F
and Figures S3, S4 and S5) indicating that the transcytosis process
of the orally introduced PrP was still going on at 1 dpf. In addition,
throughout this study, no evidence was found to indicate direct
uptake from the gut lumen via macrophages or dendritic cells, and
few NF-positive endosomes were seen in neighbouring villi. In
samples taken at later time-points (.1 dpf), the NF signals
decreased in the LAMP1-positive FAE enterocytes of all mice.
Together, these data suggest that the initial uptake of the brain
homogenate from the gut lumen occurred mainly via enterocytes
within the FAE and that the active uptake of the inoculum was still
ongoing one day after feeding.
Enterocytes within the FAE take up PrPSc
To determine whether the NF immunolabeling was related to
prion uptake from the gut lumen, we analysed subcellular
Figure 2. Subcellular localization of neurofilament and PrP uptake in FAE and SED. Neurofilaments (A) and PrP (B–F) were observed in
wild type 129/OLA mice at 1 dpf after oral prion exposure. (A) Neurofilaments (bright red) can be detected in LAMP1-positive endosomes (green) in
the FAE (white arrows) and in larger LAMP1-positive structures in macrophages in the SED. (B) PrP can occasionally be seen in small electron-lucent
early endosomal structures of FAE enterocytes, shown at higher magnification in (C, arrows). (D–F) Most of the PrP signal in FAE of infected animals is
found in LAMP1-positive, late endosomes of enterocytes. Late endosomes with electron-dense contents (arrows) are labelled with LAMP1 (D and F);
PrP was detected with PrP-specific 6H4 monoclonal antibody directly conjugated to UltraSmall gold (PrP-usg) (E and F) visualized by silver
enhancement for 5 min (E) or 1 min (F). Arrows in (E) point to PrP-usg-labelled late endosomes. (F) White arrowheads indicate PrP-specific label
within LAMP1-positive multivesicular bodies and between the apical microvilli facing the intestinal lumen. Black arrows indicate LAMP1 labelling
(15 nm gold) on the limiting membrane of these structures. A larger high resolution version of Figure 2F is provided as a supplement (Figure S4).
Scale bars: (A) 8 mm; (B) 250 nm; (C) 125 nm; (D) 600 nm; (E) 500 nm and (F) 300 nm.
doi:10.1371/journal.ppat.1002449.g002
Subcellular Trafficking of Prions in the Gut
PLoS Pathogens | www.plospathogens.org 4 December 2011 | Volume 7 | Issue 12 | e1002449
structures of the FAE for PrP accumulation by cryo-immuno EM.
No PrP-specific gold particles were found in the FAE of Peyer’s
patches from uninfected wt and Prnp-/-mice (day 0; Figure 3B). In
tissue obtained at 1 dpf, PrP-specific immunolabelling was
detected in FAE enterocytes from all mice, regardless of their
PrPC expression levels. Animals fed prion-infected brain homog-
enate showed greater PrP labelling compared to mice fed normal
brain homogenate (Figure 3B). Although the immunodetection
conditions used here do not allow discrimination between cellular
PrPC and pathogenic PrPSc, the PrP labelling in prion-exposed
mice is likely due to PrPSc. The PrP signal was occasionally found
on electron-lucent, small early endosomal vacuoles (Figure 2B and
2C), but was most abundant within large endosomal vacuoles
similar to those labelled with LAMP1 (Figure 2D–F, Figure S4 and
S5). As observed for the uptake of NF, PrP accumulated in FAE
enterocytes. Comparatively much lower levels were found in M
cells or in the enterocytes of the neighbouring villi at 1 dpf
(Figure 3B). Also similar to the NF signals, the PrP signal detected
within FAE enterocytes was transient: PrP labelling was decreased
in samples at 2 dpf, and undetectable by 14 dpf in both wt and
Prnp–/– mice (Figure 3B).
In order to discriminate the ‘‘exogenous’’ PrPSc within the orally
administered prion inoculum from ‘‘endogenous’’ PrPC or PrPC
within the prion inoculum an additional set of experiments was
performed. Groups of wt and Prnp-/- mice were fed PK-treated
brain homogenate prepared from terminally Sc327 scrapie-
infected hamsters. Immunoblot analysis confirmed that treatment
of the inoculum with PK destroyed any PrPC present within the
brain homogenate leaving proteinase-resistant PrPSc (Figure S6).
Peyer’s patches were collected at 6 and 24 hours post infection,
processed for cryo-immuno EM and sections were immunola-
belled with mAb 3F4 directly conjugated to 10 nm gold particles.
Since the mAb 3F4 recognizes only hamster PrP and does not
label mouse PrP [36], the use of this mAb ensures any PrP
Figure 3. Quantification of neurofilament- and PrP-positive late endosomes. LAMP1 positive endosomes that were also positive for
neurofilament (A) and PrP-specific gold particles (B) in wild-type and PrP-deficient mice following oral prion infection (in dpf, x axis). Similar
quantifications of NF and PrP in wt and Prnp–/– mice fed normal brain homogenate (+nbr) are also shown. Mean percentages 6 SD from the two
most proximal Peyer’s patches per mouse and two mice per group are shown for 100 randomly selected FAE enterocytes. The apical LAMP1 positive
endosomes between the brush border and nucleus were counted. In this apical region there are in average between 3 to 6 LAMP1 positive
endosomes per section of a cell. Analogously, 100 FAE M cells (M1) and 100 randomly selected villus enterocytes (E1) were analysed for LAMP1-
positive late endosomes at 1 dpf, the time point of highest scores, are also shown. NF was examined by IF; PrP was evaluated by cryo-immunogold
EM.
doi:10.1371/journal.ppat.1002449.g003
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detected is hamster-specific PrPSc from the Sc327-infected brain
inoculum, and not PrPC expressed in the host mouse. Small
clusters of gold labelling, indicative of PrPSc, were detected within
small electron-lucent early endosomal vacuoles at 6 h postfeeding
(Figure S7A and B). By 24 h after infection similar clusters of PrPSc
were detected in the lumen of multivesicular bodies (Figure S7C
and D). mAb 3F4-specific immunolabelling was observed
predominantly in FAE enterocytes both in prion-infected wt and
Prnp-/- mice, but was not detectable in control animals fed with
PK-digested normal brain homogenate. Together, these data
demonstrate that enterocytes within the FAE acquire PrPSc from
the gut lumen. Furthermore, these data also confirm that PrP
uptake from the gut lumen was independent of host PrPC
expression, and also independent of the PrP sequence of the
inoculum and therefore not affected by the species barrier between
hamster and mouse.
Together, these data suggest that both PrPC and PrPSc cross the
FAE via the endosomal system of enterocytes within the bulk flow
of transcytosed material from the gut lumen. Furthermore, our
data clearly show that the majority of PrP uptake from the gut
lumen occurs within FAE enterocytes when compared to M cells
and independently of the expression of cellular PrPC, since no
substantial differences were observed between tissues from prion-
exposed PrP-deficient and wt mice.
Prions are delivered to macrophages within the SED
Following transcytosis of brain material across the FAE, NFs
were detected within a cluster of large LAMP1-positive organelles
(Figure 2A). The SED region is known to harbour a large
population of CD11c-positive cells that are often referred to as
classical dendritic cells (DC), although they most likely represent a
heterogeneous mixture of subpopulations of classical dendritic cells
and macrophages in their different maturation forms [37,38].
Unfortunately, CD11c-specific antibodies did not work on the
aldehyde-fixed tissues used in the current study. However, most
mucosal mononuclear phagocytes and all those within Peyer’s
patch germinal centres express CD11c indicating that this marker
alone does not directly discriminate classical DC [38]. Thus, in
order to discriminate between classical dendritic cells and
macrophages, we used antibodies specific to major histocomp-
ability complex class II (MHC II) molecules to detect classical
dendritic cells and antibodies against ferritin as a marker for
macrophages (Figure 4, A and B, respectively). Macrophages
express high levels of ferritin and harbour much lower levels of
MHC II molecules on their surface (See Figure S8).
In 1 dpf samples, the macrophages within the SED harboured
large quantities of NF (Figure 2A) which co-localized with
LAMP1-positive structures. Many of these cells also appeared
strongly positive for ferritin. Ferritin-positive cells that contained
phagocytosed remnants of apoptotic lymphocytes, a landmark for
tingible body macrophages (TBMs) were found further away from
SED in the germinal centers (Figure 4C and D). In SED PrP-
specific labelling was found in late endosomes of low MHC II –
expressing macrophages by cryo-immuno EM (see Figure S9)
indicating transcytosed prion inoculum in the SED region. Some
macrophages were observed with intensely labelled intracellular
LAMP1 structures, and LAMP1-positive membrane structures
were also found in the surrounding extracellular space (Figure 4E).
These probably secreted vesicles suggested intercellular exchange
of membranous material by exocytosis and endocytosis (Figure 4E).
We conclude that within the SED, PrP mostly accumulates within
ferritin-positive macrophages, but not in MHC II–positive classical
dendritic cells.
PrPSc accumulation upon FDCs
FDCs are typically binuclear with distinct chromatin pattern
characteristics, electron-lucent cytoplasm and numerous convo-
luted extracellular extensions surrounding lymphocytes at different
stages of differentiation. These characteristics allow FDCs to be
readily identified by EM [39,40]; typical examples of FDCs
engulfing B lymphocytes are shown in Figure 5A–C.
In wt mice, oral exposure to either ME7 or RML prions
resulted in a significant increase in PrP immunolabeling on the
plasma membrane of FDCs beginning at 7 dpf (Figure 6A and B),
which increased and became more uniform in samples taken at 21
dpf (Figure 5D–E). At 105 dpf, locally high levels of PrP label were
found on FDC plasma membranes in germinal centers of PrP-
infected wt (Figure S10). The increase in PrP signal (Figure 6) was
observed only in prion-infected wt mice and was restricted to the
plasma membrane of FDCs These observations suggest that the
increase in PrP immunolobelling on FDCs of prion-infected mice
was PrPSc. Initially, the increased PrP immunolabelling was often
found heterogeneously on long dendritic extensions of single
FDCs. Increased PrP levels were simultaneously also observed in
germinal centres of mesenteric lymph nodes draining the intestines
of wt mice (data not shown).
Increased PrP labelling was not observed in wt mice fed normal
brain homogenate, suggesting that the labelling we found on FDCs
of prion-infected mice was disease-related PrPSc. No PrP
immunolabelling was observed on FDC in prion-exposed Prnp–/–
mice, indicating that the increased PrP signal was unlikely to be
due to accumulation of PrPSc from the prion inoculum. No
accumulation of PrP was observed in samples taken from wt
spleens during the first 21 dpf (data not shown). Thus, coincident
with the disappearance of PrP from FAE enterocytes, PrP
accumulated on the plasma membrane of FDCs within Peyer’s
patches and mesenteric lymph nodes in a PrPC-dependent fashion.
Together, these data imply the first site of PrPSc conversion and
replication following oral exposure.
To characterise the PrP on FDCs, and to investigate whether
protease-resistant PrPSc had formed, sections were additionally
treated with trypsin before immunolabeling with R2. This
antibody recognises an epitope of PrP containing a trypsin
cleavage site [41], and as seen previously for sections of mouse
brain infected with RML prions [42], little R2 labelling of PrPC or
PrPSc remained on FDC plasma membranes after the treatment,
either at 21 days (Figure 5F) or 105 dpf (Figure S10).
Enhanced tingible body macrophage activity within
Peyer’s patches from prion-infected mice
Further IF and cryo-immuno EM of cells in the vicinity of FDCs
revealed PrP within LAMP1-positive, late endocytic compart-
ments in cells that had all the morphological landmarks of tingible
body macrophages (TBMs) (Figure 4C and D; Figure 7; Figure
S10). TBMs are a subset of large mononuclear phagocytes that
reside in germinal centers of secondary lymphoid tissues. TBM
contain many phagocytised apoptotic cells in various states of
degradation (referred as tingible bodies). The detection of PrP
within these compartments implied that these cells were most
probably scavenging PrP. The number of TBM cell profiles
positive for PrP increased during the course of prion infection,
suggesting enhanced TBM activity in the Peyer’s patches of
infected wt mice (Figure S11). Compared to FDCs at the same
time points, a higher portion of the PrP labelling of R2 antibody in
the late endosomes / lysosomes of TBMs was unaffected after
trypsin treatment (Figure 7E and S10F), suggesting that the early
PrP labelling on FDC plasma membranes may be protease-
sensitive PrPSc, but that PrPSc targeted for degradation may have
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acquired a degree of protease resistance. Again, tissues from
uninfected mice and prion-infected Prnp-/- mice did not show PrP
in TBMs (data not shown), which argues that this increase is
specific to the propagation of PrPSc.
Early detection of prion infection within the enteric
nervous system
In samples from prion-infected wt mice obtained at 21 dpf, the
first signs of PrP accumulation within myenteric (Auerbach’s) plexi
were observed between the inner circular and outer longitudinal
layers of the muscularis in regions close to Peyer’s patches
(Figure 8A and B). In samples from prion-infected, wt mice
obtained at 105 dpf, almost all the plexi closely associated with
Peyer’s patches had strong accumulations of PrP (data not shown).
Congruent with observations above, increased PrP was only
detected within the enteric nervous systems of wt mice exposed to
prion-infected brain homogenate. We have previously shown that
caveosomes are involved in intracellular PrPC trafficking in
cultured CHO cells [43]. We found no evidence for a role of
caveosomes in PrP trafficking in vivo within the stroma of Peyer’s
patches. However, smooth muscle cells neighbouring infected
plexi appeared rich in caveosomes (Figure 8C), which often
contained PrP (Figure 8D), implying a potential mechanism
through which PrP may be disseminated within the muscle layer of
the intestine. After trypsin treatment of cryosections of prion-
infected wt animals, approximately 9% of PrP label remained on
plasma membranes of neurons at myenteric plexi of sections
collected at 21 dpf, and increased to 15% for sections obtained at
105 dpf, indicating the presence of protease-resistant PrPSc on
enteric nerves at relatively early phases of prion infection
(Figure 8E and F).
A33 links the FAE to FDCs within lymphoid follicles
The definitive epithelial marker A33 (Gpa33; [44]) is expressed
at high levels on the basolateral plasma membrane of the FAE and
villous enterocytes (Figure 9A). Although Gpa33 is not expressed by
macrophages and classical dendritic cells (See Figure S12),
cryoimmuno EM revealed the presence of A33 protein within
the endosomes of SED macrophages, indicating delivery of A33-
positive membranes from enterocytes to macrophages (Figure 9B).
Careful analysis revealed A33-positive vesicles within the germinal
centres of Peyer’s patches (Figure 9C) from each mouse group. In
contrast, no A33 immunostaining was detected in Peyer’s patches
from A33-deficient control mice, confirming the specificity of the
A33-specific antibody (Figure S13).
Weak A33 immunolabeling was also observed within the
germinal centrers of mesenteric lymph nodes, whereas those in
the spleen were negative (data not shown). The presence of small
Figure 4. Two separate subpopulations of phagocytic monocytes in SED. In the SED a subpopulation of phagocytic monocytes with large
LAMP1-positive compartments also label for ferritin, a macrophage marker. 129/Ola wild type mice were infected with ME7 prions and visualized at 1
dpf. (A) MHCII-positive dendritic cells appear to be separate populations from the cells that harbour large LAMP1 vacuoles at the SED. (B) By
comparison, cells with large LAMP1 compartments also express ferritin (red). (C and D) Apoptotic lymphocytes were seen by TUNEL staining (green in
C) inside ferritin-positive macrophages (red in C) and as electron-dense dark bodies in the late endosomal/lysosomal compartments (D). These typical
tingible body macrophages (TBMs) were found further away from SED in the germinal centre. (E) A mononuclear phagocyte at SED appears to have
exocytosed some of its LAMP1-positive endosomal compartments into the intercellular space (arrows). Scale bars: (A) and (B) 12.5 mm; (C) 8 mm; (D)
2.4 mm and (E) 200 nm.
doi:10.1371/journal.ppat.1002449.g004
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amounts of A33 antigen within the germinal centres of mesenteric
lymph nodes most likely represents membrane trafficking from the
gut epithelium to the B cell follicles as described [45]. Within the
germinal centres, A33 was present on the surface of FDCs and
often in close proximity to TBMs. It is therefore tempting to
speculate that the scavenging macrophages may be carrying
epithelial membrane components (including PrPSc on A33-positive
membranes) from the FAE to the germinal centre, where they are
deposited on the surface of the FDCs. Our EM data (Figure 9)
suggest that LAMP1-positive, late endocytic multivesicular bodies
of FAE enterocytes fuse with the plasma membrane [46], releasing
their intravesicular membrane contents as exosomes in the
extracellular space, where they may be phagocytosed within the
SED by macrophages and further spread in a ‘‘taste and spit’’ -
manner of repetitive endo- and exocytosis events by macrophages.
Consistant with this idea, exosome-like membrane structures were
shown to be positive for A33, PrP, and LAMP1 (Figure 9D–F,
respectively). Thus, together these data provide further evidence
for the association of FAE enterocyte-derived antigens such as A33
upon the surface of FDCs within Peyer’s patches and mesenteric
lymph nodes.
Discussion
Over the last few years, it has been noted that several amyloid
or protein-misfolding diseases are characterized by prion-like
propagation mechanisms [47,48]. The main difference that
distinguishes the prion diseases from other amyloid or protein-
misfolding diseases is the fact that prions can be transmitted from
one animal to another as truly infectious diseases. In many cases,
this transmission occurs via the oral route, emphasizing the
relevance of the present study. Here, we analyzed the initial uptake
of PrP from the intestinal lumen via enterocytes of the FAE. While
this initial uptake proved to be independent of the expression of
Figure 5. Increased PrP accumulation upon FDCs through the course of early prion disease. (A–E) In samples taken from Peyer’s patches
of wt mice at 21 dpf with ME7 prions, PrP accumulates in the germinal centres on the surface of mature FDCs. (A-C) Overviews show mature FDCs at
the germinal centre. (D–E) In samples taken from wt mice at 21 dpf with ME7 prions, increased PrP labelling was observed on the cell surface of FDCs.
Panel E shows an inset in D at higher magnification, with arrows indicating the silver enhanced mAb 6H4-conjugated UltraSmall gold PrP label (PrP-
usg). The arrow in panel D indicates a desmosome. (F) Trypsin treatment of sections (white bar; scrapie +T) causes an average decrease of 84% in the
amount of PrP-specific label on FDC plasma membranes of PrP-infected mice when compared to untreated sections (black bar; scrapie -T; 100%). The
remaining PrP after trypsin treatment is indicative for protease-resistant disease related PrPSc. Untreated (black bar, control -T) and trypsin-treated
(grey bar, control +T) sections from uninfected mice show little PrP-specific label. Samples were collected at 21 dpf and the FDC plasma membrane
bound PrP-specific gold was counted in untreated and trypsin treated Peyer’s patch cryosections of ME7 infected mice and noninfected controls. Ten
mature FDC cells in the germinal centre were randomly selected and 50 mm of plasma membrane was analysed per cell. A total membrane length of
500 mm per treatment was analysed and the result is given as a relative labelling density per membrane length 6 SED. L; lymphocyte. Scale bars: (A)
5 mm; (B) 2 mm; (C) 1 mm; (D) 500 nm and (E) 200 nm.
doi:10.1371/journal.ppat.1002449.g005
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cellular PrPC, the subsequent propagation and disease progression
required an endogenous supply of PrPC.
The precise cellular mechanism through which prions are
acquired from the gut lumen and transferred to FDCs within
Peyer’s patches is not known, although it has been shown that the
accumulation of prions upon FDCs within Peyer’s patches is
critical for their efficient spread to the enteric nervous system
[9,12,14]. Many other aspects of prion invasion have remained
hypothetical, especially due to the lack of physiologically relevant
in-vivo studies performed at the subcellular level. Prion detection
during the early stages of oral infection has also been a problem. In
previous immuno EM studies, PrPSc was first detected 70 days
after oral exposure and only in denatured samples [11,22].
We were able to investigate earlier stages after oral inoculation,
by using adaptations of high-resolution methods developed in
previous studies [42,49]. The GALT are filled with endogenous
immunoglobulins, which limit the use of mouse antibodies for
immunodetection. However, many PrP-specific monoclonal anti-
bodies (e.g., mAb 6H4 [50] and mAb R2 [51]) were raised in
Prnp–/– mice. To avoid interference of endogenous mouse
immunoglobulins and to permit better penetration in the tissue
analysed, we collaborated with Aurion (Wageningen, The Nether-
lands) to conjugate mAb 6H4 and Fab fragments mAb R2 to
UltraSmall gold particles. The PrP binding sites were visualised by
silver enhancement, which enabled us to detect directly by EM the
binding sites of the primary PrP antibody. Unconjugated R2 Fab
fragments and UltraSmall gold-labelled Fab fragments of another
PrP antibody have previously been used for IF and cryo-immuno
EM on normal and prion-infected mouse brain, and R2 has been
shown to recognize both PrPC and PrPSc on undenatured tissue
sections [42,51]. By applying these novel PrP antibody derivates,
we gained higher PrP detection levels and were able to follow PrP
Figure 6. An increase of PrP label upon FDCs of wt mice only. Quantification of PrP label on the plasma membrane of FDCs indicates a clear
increase of PrP label in wt mice between 2 and 7 dpf with either ME7 (A) or RML (B) prions compared to wt and PrP-/- animals that were fed with
normal brain homogenate (nbr) or PrP-/- animals fed with ME7 or RML prions, respectively. The labelling density was counted as gold particles/
membrane length (mm). The x axis indicates the number of days after oral infection at which samples were taken. A gold particle was defined as
membrane associated if it was not further than 20 nm away from the membrane leaflet. The two most proximal Peyer’s patches per mouse and two
mice per group were analysed. Only plasma membranes of cells with typical FDC morphology in GCs (cells with lightly electron-lucent, bilobular
nucleus that were in cellular contact with $1 non-apoptotic lymphocytes) were counted. A total membrane length of 1000 mm per sample was
analysed. Asterisks indicate a statistically significant difference between wt mice infected with prions compared to other groups, p,0,05.
doi:10.1371/journal.ppat.1002449.g006
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trafficking in nondenatured GALT as early as 1 dpf, as inoculated
PrP, and 7 dpf, as replicating PrP on the surface of FDCs.
The results of our time-course studies, employing IF and cryo-
immuno EM with two distinct in-vivo mouse models, revealed the
cellular and intracellular sites of prion trafficking after oral prion
infection. Figure 10 represents a proposed model for prion
neuroinvasion from gut lumen via Peyer’s patches to enteric
nervous system based on the results of the present study. In all gut
samples examined, we found PrP accumulation in large, late
endocytic multivesicular bodies of FAE enterocytes. Although PrP
was also observed within M cells, this was at much lower levels
than that within FAE enterocytes. Furthermore, our data indicated
that PrP transcytosis across the FAE was independent of cellular
PrPC expression. In prion-infected wt mice, we subsequently found
PrP in late endosomes of SED macrophages followed by a gradual
increase upon the surface of FDCs within germinal centres.
Relatively large amounts of PrP could also be found in late
endosomes of TBMs in germinal centres. Subsequently, beginning
at 21 dpf, and following accumulation upon FDCs, increased
levels of PrP were observed on the surface of neurons at
submucosal and myenteric plexi. At 105 dpf (approximately one
third through the incubation period for 129/Ola mice orally
exposed to ME7 scrapie prions) PrP-immunolabelling on neurons
had increased.
Figure 7. PrP positive endosomes in the germinal centre of Peyer’s patch of wt mouse exposed to ME7 prions. Silver enhanced cryo-
immuno EM labeling of PrP with mAb 6H4 conjugated to UltraSmall gold (PrP-usg) shows increased numbers of PrP-positive late endosomes and
lysosomes of tingible body macrophages (TBMs) in germinal centres of wt mice at 21 dpf. Areas framed by white lines in panels A and C are shown at
higher magnification in panels B and D, respectively. Arrows in B and D point to PrP-positive, late endosomes/lysosomes. L; lymphocyte. (E) After
trypsin treatment an average of 48% of the PrP-specific label (white bar; scrapie +T) remains in the lumen of late endosomes/lysosomes of PrP-
infected mice when compared to untreated PrP-infected mice (black bar; scrapie -T; 100%). The remaining PrP after trypsin treatment is indicative for
protease-resistant disease related PrPSc. Untreated (black bar, control -T) and trypsin-treated (grey bar, control +T) uninfected mice show little late
endosome/lysosome associated PrP-specific label. Samples were collected at 21 dpf and the PrP-specific gold was counted in the lumen of late
endosomes/lysosomes of tingle body macrophages in germinal centres of untreated and trypsin treated cryosections of Peyer’s patch from ME7
infected mice and noninfected controls. A total of 100 late endosomes/lysosomes per treatment were analysed and the result is given as a relative
labeling density per area 6 SED. Scale bars: (A) and (C): 1 mm; (B) 300 nm and (D) 250 nm.
doi:10.1371/journal.ppat.1002449.g007
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Figure 8. First PrP observed in myenteric plexi. PrP labelling is observed in myenteric plexi in samples from wt mice taken at 21 dpf. (A)
Overview of the edge of a Peyer’s patch (PP), submucosa (S) and the underlying muscle layer (Mu). The arrow points to the myenteric plexus. (B)
Higher magnification view of the plexus (boxed area in A) shows a high density of silver enhanced PrP label (mAb 6H4 conjugated to UltraSmall gold
(PrP-usg)) on the plasma membrane of myenteric neurons. (C and D) Micrographs show that the smooth muscle cells surrounding the plexi have
numerous electron lucent caveosomes on their surface (arrows in C indicate caveosome-rich areas, arrowheads in D indicate individual caveosomes),
some of which are PrP-positive (arrows in D). Dotted line in C depicts the border between the plexus and muscle layer. (E and F) After trypsin
treatment an average of 9% at 21 dpf (E) and 15% at 105 dpf (F) of the PrP-specific label (white bar, scrapie +T) remains on the surface of neurons at
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Our observations of increasing PrP on FDCs are consistent with
previous reports. However, our data did not support the prevailing
view concerning the initial uptake and trafficking of orally
administered prions. In the gut, the FAE-overlying follicles of
the mucosa-associated lymphoid tissue are key players in initiating
mucosal immune responses and are strongly suspected to be the
major entry site from the intestine into the lymphoid and nervous
systems in animals orally infected with prions [22]. Within the
FAE specifically, an in-vitro study suggested that M cells were the
main target and gatekeepers for prion invasion [18,19,21]. In
contrast, data from our in-vivo study suggest that M cells are not the
primary target for prion entry through the FAE. Instead, most of
the PrP was found in the endosomes of enterocytes within the
FAE. These appear to be specialized enterocytes with enlarged late
endosomal compartments compared to the ‘‘normal’’ enterocytes
in the villi.
Data in the current study appear to differ significantly between
those data in the study by Foster et al. [21] where PrP was mainly
detected in association with Peyer’s patch and cecal patch M cells.
The reasons for this apparent discrepancy are uncertain. In the
current study mice were fed doses of scrapie prions that require
amplification in the GALT prior to neuroinvasion [9,25]. The use
of such physiologically-relevant doses is important as direct
neuroinvasion can occur following exposure to higher doses. In
the Foster study [21] a substantially higher dose of prions was
delivered directly into the stomach of recipient mice than that used
in the current study. Due to the high concentration of prions
within the intestine it is plausible that other cell populations were
principally involved in acquiring prions.
We found indirect evidence that the FAE enterocytes may
exocytose the intravacuolar contents (including endocytosed PrP
from the gut lumen) of their late endosomes into the extracellular
Figure 9. The endothelial marker A33 is found in FAE and SED of Peyer’s patches from wt mice. (A) A33 (red) labels basolateral plasma
membranes of FAE enterocytes. (B and C) Some A33-positive membrane components can be found in association with LAMP1-positive (green)
subcellular compartments on (B) dendritic cells/macrophages in the subepithelial dome (SED; arrows) as well as (C) on the cell surfaces of the FDC
network on germinal centres (GC). (D–F) Some multivesicular bodies of FAE seem to fuse with the plasma membrane (arrows in D and E; PM; dotted
line), releasing their intravacuolar membranes as exosomes into the extracellular space (arrows in F). For these images 129/Ola wt mice were infected
and analysed at 7 dpf. V; villus. Labeled antigens: A33 (D); PrP (silver enhanced mAb 6H4 conjugated to UltraSmall gold, PrP-usg) (E) and LAMP1 (F).
Scale bars: (A–C) 20 mm; (D–E) 200 nm; and (F) 250 nm.
doi:10.1371/journal.ppat.1002449.g009
myenteric plexi of PrP-infected mice when compared to untreated PrP-infected mice (black bar; scrapie -T ; 100%). Untreated (black bar,control -T)
and trypsin-treated (grey bar, control +T) uninfected mice show little myenteric plexi associated PrP-specific label. The PrP-specific gold was counted
on the surface of neurons at the myenteric plexi of untreated and trypsin treated cryosections of Peyer’s patch from ME7 infected mice and
noninfected controls. A total of 10 myenteric plexi per treatment were analysed and the result is given as a relative labelling density per area 6 SED.
Scale bars: (A) 4 mm; (B) 300 nm; (C) 250 nm and (D) 200 nm.
doi:10.1371/journal.ppat.1002449.g008
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space of the SED. These exosome-like structures (for a review, see
[52]) are LAMP1- and A33-positive and may be part of normal
machinery [45] for antigen presentation to the immune system,
since we found traces of the epithelial marker A33 within
macrophages and upon FDCs. The concept of exosomes as
membrane carriers was originally described in [53]. A33-related
exosome secretion from intestinal epithelium has been described in
general [54] and specifically related to prion transmission upon
oral challenge [55]. However, it is difficult to find direct evidence
for this highly dynamic process at the ultrastructural level in in-vivo
models.
Genetic ablation of PrP abrogates susceptibility of mice to prion
diseases [4]. For PrP trancytosis through the FAE, PrPC is not
required, since transcytosis also occurs in PrP-deficient animals.
Therefore, we conclude that PrP is likely to be transcytosed across
the FAE in a non-specific manner within the bulk flow of other
lumen-derived, digested, and endocytosed material. After transcy-
tosis through the FAE, the migrating CD11c-positive cells
Figure 10. Proposed model for the for prion neuroinvasion from gut lumen via Peyer’s patches to enteric nervous system. (1) Data in
the current study suggest that prion uptake from gut lumen occurs predominantly via large LAMP1 positive endosomes of FAE enterocytes with (2)
much lower levels via M cells. (3) FAE enterocytes release prions to SED with Gpa33+ exosomes. (4) SED macrophages uptake and release Gpa33+
exosomes and prions to their environment. (5) Prions and Gpa33+ exosomes spread to the germinal centers by TBMs (6) Prions and FAE-derived
Gpa33+ exosomes accumulate on surface of FDCs in the germinal centers. Prions start to replicate on the surface of FDCs. (7) Prions replicate and
spread to CNS via enteric nerves close to Peyer’s patches.
doi:10.1371/journal.ppat.1002449.g010
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(generally considered to be classical dendritic cells within the SED)
are thought to endocytose and transfer the prions to germinal
centres where prion replication may occur [25]. From there, by as-
of-yet unknown cellular mechanisms, the prions are able to infect
the peripheral enteric nervous system and gain further access to
the main pathological target of prion diseases, the central nervous
system. In macrophages of the SED, we found PrP in LAMP1-
positive compartments of ferritin-positive cells and to a lesser
extent in MHC II-positive cells (Figure S9). These observations
suggest that PrP trafficking through the SED occurs in endosomal
compartments of more macrophage-like mononuclear phagocytic
cells rather than classical dendritic cells. Furthermore, in the SED,
PrP was only detected in endosomal compartments of these
macrophages and not on the cell surface. Transient depletion of
CD11c-positive cells before oral exposure to prions has been
shown to markedly delay the course of neuroinvasion [25]. When
we retrospectively analysed the Peyer’s patches of these CD11c-
positive-cell-depleted mice (diphtheria toxin–treated, CD11c-
diphtheria toxin receptor-transgenic mice), we found that the
ferritin-positive macrophages within the SED were likewise
transiently depleted (unpublished data). Interestingly, protease-
resistant PrP has been reported to be transcytosed in a complex
together with ferritin through intestinal epithelial cells [23], but the
relevance of this finding for the ferritin-positive macrophages that
are active in PrP endocytosis remains unclear.
The subsequent accumulation of PrP upon the surface of FDCs
was only observed in Peyer’s patches from orally exposed wt mice,
and increased throughout the duration of the experiment. These
PrPC-expressing, nonmigratory cells have a limited endosomal/
phagocytic apparatus and are specialized to present native
immuno complexes on their surface. These observations strongly
suggest conversion and replication of PrPSc de novo upon the
surfaces of FDCs and not merely the accumulation of inoculated
PrPSc.
Taken together, these observations implicate two cellular
compartments with distinct roles during the initial stages of
orally-acquired prion disease: (1) endosomal compartments active
in transient transcytosis and/or degradation/storage of PrPSc
(LAMP1-positive endosomes in FAE enterocytes, M cells, villous
enterocytes, SED macrophages, and germinal centre TBMs, and
caveosomes in submucosal smooth muscle cells) and (2) the cell
surface of FDCs and enteric neurons, where prion replication most
likely occurs. Importantly, no increase of PrP surface labelling was
observed on macrophages in the course of the early infection, even
if they had high labelling densities in their endosomal compart-
ments. Our data suggest uptake into the endosomal compartments
occurs independently of cellular PrPC expression, whereas PrP
accumulation upon FDCs and enteric neurons is critically
dependent upon the expression of PrPC. Further, we were able
to confirm the relevance of our results by using three different
mouse infection models, with Prnp-/- mice resistant to disease as
controls.
In our previous cryoimmuno EM studies, on FVB mouse
hippocampus infected with RML prions, the PrPC levels were also
specifically examined and were not found to increase as a result of
prion disease. Increases in R2 labelling could thus be attributed to
the formation of PrPSc. This labelling was also mainly on plasma
membranes and on early endocytic or recycling vesicles rather
than late endosomal compartments [42].
A high proportion of the R2 labelling in RML prion-infected
FVB hippocampus was found to be trypsin sensitive [42], as was
the case with the labelling on FDCs and enteric neurons in the
present study. These results are consistent with reports that
protease-sensitive forms of PrPSc predominate in some types of
prion disease [56,57]. Prions in the oral inoculum probably
included protease-resistant forms that were able to withstand the
general proteolytic degradation that occurs in the intestinal lumen
and be processed by the endosomal machinery of FAE enterocytes
without losing their infectivity.
We observed a spread of PrPSc to secondary lymphoid tissues.
This may be due to several different mechanisms. First, PrPSc may
spread by cell-cell contacts within the Peyer’s patches and via
lymphatics to the mesenteric lymph nodes. Additionally, the local
concentration of the prion inoculum appears to have an impact on
the speed of disease progression, which could explain why PrP
accumulates first in Peyer’s patches, where the enlarged endocytic
capacity of FAE enterocytes sufficiently loads the locally dense
population of SED macrophages.
We cannot exclude the possibility that the intestinal routing of
prions after oral exposure may vary depending on the combination
of prion and host strain. To address this issue in the current study,
we used two different mouse-passage prion isolates that have been
shown to have distinct cellular requirements for replication in
lymphoid tissues [2,27] and the hamster-passaged Sc237 scrapie
strain. Our analysis showed consistent data from each of these
distinct prion agents. However, there are examples of other prion
strain and host combinations that do not appear to require
accumulation and amplification in the GALT prior to neuroinva-
sion, such as BSE in cattle [58], some strains of TME [59], CWD
in some cervid species [60] and atypical scrapie [61]. Of course, in
each of these examples, the prions must still be transcytosed across
the FAE prior to establishing infection within enteric nerves in the
submucosa.
At 105 dpf (the latest time point we examined), the increased
PrP labelling remained restricted to germinal centres and their
neighbouring enteric plexi. For clarity, at 105 dpf, the animals
infected with ME7 did not show any clinical symptoms of prion
disease. The onset of clinical signs were observed at approximately
272 dpf at the dose we used in our studies. PrPSc has been reported
to be found in the FAE of perorally challenged hamsters at 60 days
[6] or 69 days [8] after intestinal infection with 263K scrapie, and
it has been suggested that the FAE might serve as a site for prion
release from the host some time after oral infection. In our study,
we did not see a spread of PrPSc back to the FAE. 263K scrapie is
considered to be a highly neurotropic prion strain, whereas ME7 is
considered more lymphotropic. One could argue that during
263K scrapie infection, PrPSc returns to the gut epithelium via
infected enteric nerves which presumably infiltrate the FAE. The
same nerves may have been infected at the time of prion exposure.
This does not appear to occur in mice, or if it does, it happens at
later stages in the incubation period.
Together, these data suggest that uptake via large late
endosomal compartments of FAE enterocytes represents a novel
potential M cell-independent mechanism through which prions
are acquired from the gut lumen. While these data do not exclude
a role for M cells or villous enterocytes in the initial uptake of
prions from the gut lumen, much lower levels of PrP were detected
within them when compared to FAE enterocytes. Our data show
that the transcytosis of prions to the germinal centres of Peyer’s
patches is PrPC-independent as it occurs also in PrPC-deficient
animals. In contrast, PrPC expression is required for the observed
high labelling densities on plasma membranes of FDCs and enteric
neurons. Indeed, our data suggest that FDCs within Peyer’s
patches are the first site of prion conversion and replication after
oral exposure. These findings provide insight into the subcellular
localisation and trafficking of prions, which might provide suitable
targets to arrest oral prion infection. Furthermore, these data
identify a novel, previously unrecognised, enterocyte-dependent
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route of prion uptake and transfer from the gut lumen that may
have an important influence on susceptibility to oral prion
infection.
Materials and Methods
Mice and oral prion exposure
Prnp-/- mice were bred and maintained on a 129/Ola
background [33]. Age- and sex-matched 129/Ola mice were used
as wt controls. For oral infection with ME7 prions, both wt and
Prnp-/- (n=12 for each group) were fed individual food pellets
doused with 50 ml of a 1% (wt/vol) brain homogenate prepared
from wt mice terminally affected with ME7 scrapie prions. Food
pellets doused with 50 ml of a 1% (wt/vol) brain homogenate
prepared from uninfected mice (‘‘normal brain homogenate’’)
were used as a control. These experiments were approved by the
Roslin Institute’s Protocols and Ethics Committee and carried out
according to the strict regulations of the UK Home Office
‘Animals (scientific procedures) Act 1986’.
For oral infection with RML prions, wt FVB and Prnp-/- mice
(n=10 for each group) were infected by gavage with 100 ml of 1%
brain homogenate from wt mice infected with mouse-adapted
RML scrapie prions. An additional group of 6 wt and 6
Prnp-/-mice was infected with 1% brain homogenate from Syrian
hamsters infected with hamster-adapted Sc237 scrapie prions. As
respective controls, 100 ml of 1% brain homogenates prepared
from uninfected wt mice or Syrian hamsters was administered by
gavage as well. The brain homogenates from infected and
uninfected Syrian hamsters were treated with proteinase K before
being administered to the mice (See legend of Figure S6 for more
details). The ME7 and RML samples were used without
proteinase treatment. Use of these mice was according to the
Public Health Services/National Institutes of Health Guide for the
Care and Use of Laboratory animals. A33-deficient mice were
created as described [62].
Tissue collection, fixation and cryo-sectioning
Mice were culled at 0, 1, 2, 7, 14, 21 and 105 dpf, and Peyer’s
patches, mesenteric lymph nodes, and spleens were collected and
prepared for IF and cryoimmuno EM. Briefly, tissue samples were
dissected from animals and immersion-fixed in a solution
containing 2% paraformaldeyde and 0.2% glutaraldehyde in
PHEM-buffer (25 mM HEPES, 10 mM EGTA, 60 mM PIPES,
2 mM MgCl2; pH 7.2). Fixed tissues were embedded in gelatin,
infused in sucrose, and frozen in liquid nitrogen [63]. Frozen
samples were cut on a cryo-ultramicrotome as semithin sections
for IF (200 nm, -100uC) or as ultrathin sections for cryoimmuno
EM (70 nm, -120uC). Sections were picked up with sucrose for IF
or with a mixture of methylcellulose/sucrose for cryo-immuno
EM.
Reagents and antibodies
M cells were identified with biotinylated Ulex europaeus (UEA-1)
lectin (L8262; Sigma). Bound lectin was detected with polyclonal
rabbit anti-biotin (Rockland). The following primary antibodies
were used for immunolocalisation by IF and/or cryo-immuno
EM: monoclonal rat anti-LAMP1 (1D4B; BD Biosciences
Pharmingen); rabbit polyclonals MHCII (JV2; generous gift from
Dr. Hidde Ploegh); anti-neurofilament 200 (Sigma); anti-ferritin
(F5012; Sigma); goat polyclonal anti-A33 (AF2756; R&D
Systems); rabbit polyclonal anti-annexin V (Ab14196; Abcam);
rat monoclonal anti-GP2/glycoprotein 2 (D277-3; MBL); mono-
clonal anti-PrP 6H4 [49] R2 [50] and polyclonal 1B3 [64]. To
detect hamster PrP biotinylated mAb 3F4 (SIG-39640 Covance
Signet Antibodies) [36] directly conjugated to Streptavidin Gold
Nanoparticles (Nanocs) was used. The following secondary
bridging antibodies were used for cryo-immuno EM when rat or
goat primary antibodies were applied: polyclonal rabbit anti-rat
and rabbit anti-goat (DAKO), respectively.
Immunofluorescence analysis
For IF microscopy, semithin cryosections on glass slides were
labelled with primary antibody, followed by species-specific
secondary antibodies coupled to Alexa Fluor 488 (green) or Texas
red dyes (Invitrogen, Paisley, UK). Sections were mounted in
fluorescent mounting medium (DakoCytomation) and examined
using a Zeiss LSM5 confocal microscope (Zeiss, Welwyn Garden
City, UK). Simultaneous Dapi staining was applied to visualise the
nuclei and the cellular organisation of the tissue. To prevent
possible false-positive signals caused by autofluorescence, sections
were treated with 1% sodium borate for 5 min. A TUNEL assay
was performed using the fluorescein-conjugated in situ Cell death
Detection kit (Roche Applied Science) according to the manufac-
turer’s instructions.
Cryo-immunogold EM
For cryoimmunogold EM, PrP-specific 6H4 [49] and Fab-
fragments of R2 antibodies [50] were conjugated to UltraSmall
gold particles (0.8 nm; Aurion, Wageningen, The Netherlands) to
allow increased penetration into the cryosections and circumvent
labeling artefacts caused by cross-reaction with endogenous
immunoglobulins in the tissue. Labeling reactions were performed
under native conditions; no antigen retrieval method was applied.
The R-GENT SE-EM silver enhancement kit from Aurion was
used according to the manufacturer’s instructions. For other
immunogold-labelling experiments, the primary antibody, or the
bridging antibody, was detected via the standard protein A–gold
method [63]. For double labelling, conjugates of PrP-specific
antibody and UltraSmall gold were applied and briefly silver
enhanced, prior to incubation with the second primary antibody
that was subsequently detected by protein A–gold.
The immunolabeling of sections was done as described
previously [63]. In brief, after blocking with 1% cold fish gelatin
and 1% bovine serum albumin for 15 min, sections were
incubated with primary antibody for 60 min, washed, and
bridging rabbit antibodies were applied for 30 min when
necessary. Sections were then incubated with protein A-gold
(15 nm) for 20 min. The specificities of the antibodies were
controlled by omission of the primary antibody. Labeled sections
were viewed with a Philips CM10 electron microscope (FEI
Company, Eindhoven, The Netherlands) at 80 kV.
Quantification
The quantification of the distribution of gold particles was done
according to routine stereological methods in double-blind
fashion. Data are presented as means 6 SD. Data were analysed
using a T-test and differences were considered significant when
p,0.05.
Supporting Information
Figure S1 FAE enterocytes have larger late endosomes
than enterocytes in the neigbouring villi or M cells in
FAE. (A) and (B) show IF images of FAE double labelled with
epithelium-specific A33 (red) and late endosomal marker LAMP1
(green). Nuclei are labelled with Dapi (blue). The large FAE
endosomes are apical to the nuclei. (C) Histochemistry section of
Peyer’s patch labelled with LAMP1 reveals the different
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morphology of the regular shaped apical FAE endosomes (red
filled arrows) and the more pleiomorphic endosomes of SED
macrophages, two of which seem to intrude into the FAE (black
arrows). (D) EM micrograph of the large apical endosomes
(arrows) of the FAE enterocytes located between the nuclei and the
brush border. (E) The diameters of 100 LAMP1-positive
endosomes in FAE enterocytes, villus enterocytes and M cells of
2 wild-type animals were measured. The average diameter of the
LAMP1-positive endosomes of FAE enterocytes is significantly
larger (p,0.05). Abbreviations: bb, brush border; G, goblet cells;
ent, enterocyte; N, nucleus. Scale bars (A–C) 25 mm; (D) 750 nm.
(PDF)
Figure S2 Distinguishing M cell and goblet cells by
morphology and cellular markers. (A) Typical M cells at
FAE labelled with UEA-1 lectin. (B) goblet cells at the villi labelled
with UEA-1. (C) Partial colocalization of M cell markers UEA-1
(red) and GP-2 (green) on FAE brush borders. (D) GP-2 (green)
labels the brush borders of cells double labelled with a cytoplasmic
M cell marker annexin V (AnxV, red) at FAE. Transmission EM
micrographs of FAE reveal the clear morphological differences
between M cells with typical short microvilli at their brush border
(E), and the occasionally present goblet cells with their large apical
mucus-containing secretory granules (F). Scale bars (A–D) 25 mm;
(E–F) 500 nm.
(PDF)
Figure S3 A high resolution version of Figure 1F of the
original manuscript. As with many cells active in water
transport, FAE enterocytes and M cells have dilated intercellular
spaces filled by interdigitating membrane leaflets. The microvilli of
the M cells are heavily labelled with UEA-1 lectin (15 nm gold
depicted with white arrows at the apical plasma membrane facing
the intestinal lumen). In this micrograph some of the UEA-1
labelled leaflets (thick white arrows at the basolateral plasma
membrane) of a M cell come close to the PrP positive endosomal
vacuole labelled with (black arrow) in the cytoplasm of an FAE
enterocyte and can be seen as a cross section. The dilated
intercellular spaces and interdigitating membrane leaflets can be
seen more clearly in Figure S5. PrP was detected with PrP-specific
6H4 monoclonal antibody directly conjugated to UltraSmall gold
(PrP-usg) and visualized by silver enhancement.
(PDF)
Figure S4 A high resolution version of Figure 2F of the
original manuscript. Boxed areas (a) and (b) in the left image
are shown, right, at higher magnification. Black arrows indicate
PrP-specific label between the apical microvilli facing the intestinal
lumen (a) and within a multivesicular body (b). White arrowheads
indicate LAMP1 labelling (15 nm gold) on the limiting membrane
of these structures. PrP was detected with PrP-specific 6H4
monoclonal antibody directly conjugated to UltraSmall gold (PrP-
usg) and visualized by silver enhancement.
(PDF)
Figure S5 ME7 infected wt mice have detectable
amounts of PrP-labeled brain inoculum in the gut lumen
at 1 dpf. A high resolution EM micrograph of the apical surface
of an FAE enterocyte facing the gut lumen shows PrP-specific label
(black arrows) in the lumen of an apical multivesicular body in
boxed area (a) and in the gut lumen and between the microvilli
facing the gut lumen in boxed area (b) better seen in the enlarged
images below. PrP was detected with PrP-specific 6H4 monoclonal
antibody directly conjugated to UltraSmall gold (PrP-usg) and
visualized by silver enhancement. The section was double labelled
with late endosomal marker LAMP-1, which was detected with
protein A conjugated to 15 nm gold (white triangles) present on
the limiting membrane of the endosome. Note the dilated
intercellular spaces filled by interdigitating membrane leaflets.
Scale bar 300 nm.
(PDF)
Figure S6 Oral administration of FVB (wt) and Prnp-/-
mice with PK-treated Sc237 SHa brain homogenate.
Briefly, for oral infection via gavage 6 FVB (wt) and 6 Prnp-/- mice
were exposed to PK-treated Sc237 Syrian hamster (SHa) brain
homogenate. Three animals of both groups were sacrificed by
cervical dislocation after 6 hours and the rest at 24 hours post
infection. Animals were dissected and intestine was cut into 2–
3 cm pieces and immersion-fixed in 2% PFA + 0.2% GA in
PHEM buffer and processed for IEM as described in the Materials
and methods. For controls 2 FVB and 2 Prnp-/- mice were exposed
to PK-treated normal SHa brain homogenate. These animals were
sacrificed after 6 and 24 hours after exposure and processed
identically to the others. Brain homogenates (20% w/v) were
digested with proteinase K (PK, 50 mg/ml at 37uC for 1 hour) in
the presence of 2% Sarkosyl. The digestion was stopped by
addition of 1 mM PMSF. Afterwards the brain homogenates were
diluted to 10%, effectively reducing the Sarkosyl concentration to
1% and used in the oral exposure experiments. Prior to their use
the PK-treated SHa brain homogenates (Sc237-infected and
uninfected) were tested by Western blotting (using mAb 3F4) to
confirm the complete digestion of PrPC and the truncation of
PrPSc to the PK-resistant PrP 27–30 core, respectively. (A)
Western blot analysis of the hamster brain homogenates used for
the mouse oral exposure experiment. Lanes 1 and 2 were loaded
with uninfected Syrian hamster brain homogenate with or without
PK treatment, respectively. Lanes 3 and 4 were loaded with brain
homogenate from Sc237-infected Syrian hamsters with and
without PK treatment, respectively. Quantitation of 3F4 positive
endosomes in wt- mice (B) and Prnp-/- mice (C) 6 and 24 hours
after exposure to PK-treated Sc237 SHa brain homogenate. For
quantitation approximately 300 endosomes of FAE enterocytes
(FAE), M cells (M) and villus enterocytes (E) were counted for each
animal. Each bar represents percentage of 3F4 positive endosomes
at given time point in total and gives the ratio of 3F4-positive
electron-lucent early endosomal structures (EE) compared to 3F4-
positive multivesicular bodies (MVB). For IEM analysis the Peyer’s
patch most proximal to the stomach of each animal was examined.
The FAE and SED regions were immunostained using biotiny-
lated mAb 3F4 (Covance Research Products). mAb 3F4 recognizes
only PK-treated hamster PrPSc. To exclude interference from
endogenous immunoglobulins mAb 3F4 was conjugated directly to
Streptavidin Gold Nanoparticles with 10 nm gold (Nanocs).
(PDF)
Figure S7 PK-treated hamster brain-derived prion
inoculum is found in early endosomes and multivesic-
ular bodies of FAE enterocytes. Electron micrographs reveal
hamster PrP-specific labelling in small electron-lucent early
endosomes at 6 h (A and B) and in multivesicular bodies at 24 h
(C and D) after exposure to PK-treated Sc237 SHa brain
homogenate. Sections of the most proximal Peyer’s patch were
labelled with mAb 3F4 directly conjugated to 10 nm gold. A and
D are sections of wt mice and B and C from Prnp-/- mice,
respectively. Similar PrP-positive endosomes were observed in oral
exposure experiments with PrP-infected mouse brain homogenate
(see Figure 2 in the main article).
(PDF)
Figure S8 Microarray analysis of expression of ferritin
light chain, major histocompatibility complex class II
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invariant chain and CD11c in macrophages and den-
dritic cells of different tissue-specific origin. Analysis of
304 individual microarray data sets representing 1: bone marrow;
2: bone marrow progenitors; 3: bone marrow-derived macro-
phages; 4: peritoneal macrophages; 5: osteoclasts, microglia,
Langerhans cells; 6: bone marrow-derived dendritic cells; 7:
splenic, Peyer’s patch and lymph node dendritic cells; 8:
plasmacytoid dendritic cells; 9: natural killer cells/ IFN-producing
killer dendritic cells; 10: myeloblasts and neutrophils; 11: B cells;
12: T cells. Adapted from Mabbott et al. (2010) Immunobiology
215:724-736.
(PDF)
Figure S9 SED macrophages uptake prion inoculum. (A)
and (B) The PrP-containing brain inoculum is found in late
endosomes of SED macrophages beneath the FAE at 1 dpf. The
PrP (small black arrows) can be seen more clearly in the enlarged
images (a) and (b) It was detected with PrP-specific 6H4
monoclonal antibody directly conjugated to UltraSmall gold
(PrP-usg) and visualized by silver enhancement. The section was
double labelled with MHC class II antibody, which was detected
with protein A conjugated to 15 nm gold (small white arrows in
the blow ups). In accordance with immunofluorescence data in
main manuscript Figure 4 the phagocytes that engulf PrP
inoculum express low levels of MHC class II (marker of antigen
presenting cells/ classical dendritic cells) on their surface. Note also
the extracellular exosome–like vesicles that are being either
exocytosed or phagocytosed by the macrophage (big black arrow).
Scale bars in (A) and (B) 200 nm; in enlarged inserts (a) and (b)
100 nm.
(PDF)
Figure S10 Peyer’s patch of ME7 infected wt mice at 105
dpf. (A) and (B) Immunofluorescence detection of PrP-specific
label in the germinal centres. In (A) the cryo section was labeled
with rabbit polyclonal 1B3 and detected with goat anti-rabbit
conjugated to Texas Red. In (B) section was double labelled with
1B6 (red) and rat monoclonal LAMP-1 (green). PrP is found on the
plasma membrane of FDC and LAMP-1 positive late endosomes/
lysosomes of tingible body macrophages (TBMs, white arrow in
(B). Cryo immunogold EM reveals large accumulations of PrP
upon FDC plasma membranes (C) and TBM late endosomes/
lysosomes (D). The EM sections were labelled with R2-antibody
directly conjugated to UltraSmall gold (PrP-usg) and visualized by
silver enhancement. (E) After trypsin treatment an average of 18%
of the PrP-specific label (white bar; scrapie +T) remains on FDC
plasma membranes of PrP-infected mice when compared to
untreated tissue sections from PrP-infected mice (black bar; scrapie
–T; 100%). The remaining PrP after trypsin treatment is indicative
for protease-resistant disease-related PrPSc. Untreated (black bar,
control -T) and trypsin-treated (grey bar, control +T) uninfected
mice show little PrP-specific label. Samples were collected at 105
dpf and the FDC plasma membrane bound PrP-specific gold was
counted in untreated and trypsin treated Peyer’s patch cryosec-
tions of ME7 infected mice and noninfected controls. Ten mature
FDC cells in the germinal centre were randomly selected and
50 mm of plasma membrane was analysed per cell. A total
membrane length of 500 mm per treatment was analysed and the
result is given as a relative labeling density per membrane length
6 SD. (F) After trypsin treatment an average of 56% of the PrP-
specific label (white bar; scrapie +T) remains in the lumen of late
endosomes/lysosomes of PrP-infected mice when compared to
untreated sections from PrP-infected mice (black bar; scrapie –T;
100%). The remaining PrP after trypsin treatment is indicative for
protease-resistant forms of disease-related PrPSc. Untreated (black
bar,control -T) and trypsin-treated (grey bar, control +T)
uninfected mice show little late endosome/lysosome associated
PrP-specific label. Samples were collected at 105 dpf and the PrP-
specific gold was counted in the lumen of late endosomes/
lysosomes of tingible body macrophages at the germinal centre of
untreated and trypsin treated Peyer’s patch cryosections of ME7
infected mice and noninfected controls. A total of 100 late
endosomes/lysosomes per treatment was analysed and the result is
given as a relative labellng density per area 6 SED. Scale bars (A
and B) 25 mm and (C and D) 200 nm.
(PDF)
Figure S11 The number of PrP-positive late endosomes
in TBMs increased during the early course of prion
infection. Quantification was performed on Peyer’s patches of 2
ME7-infected, wt mice at the time-points indicated (x axis).
Percentage of TBMs with PrP- and LAMP1-positive endosomes in
germinal centres are indicated relative to the total TBMs observed.
A total area of 100 mm2/animal in the germinal centre was
analysed.
(PDF)
Figure S12 Expression of Lamp1, Gpa33 and Prnp
mRNA in murine tissues and cells. (A) Gene expression
analysed using the Reference Database of Immune Cell types
(RefDIC; Hijikata et al. (2007) Bioinformatics 23, 2934-2941).
Detailed conditions of cell and tissue preparation and treatment
are available on the RefDIC website (http://refdic.rcai.riken.jp/
welcome.cgi). mRNA expression was analyzed in different cell
types from different organs, as indicated by the top row and
corresponding key. Normalised expression level data for each gene
are shown (second to forth rows) as a gradation from green (low) to
red (high). DC, dendritic cells; F, follicle-associated epithelium;
FDC, follicular dendritic cell; V, villus epithelium; Mast, mast
cells; NK, NK cells; NKT, Natural killer T cells; Neut, neutrophil;
Lk, Peyer’s patch leukocytes. (B) Expression profile of Gpa33 in 61
murine tissues and cells analysed using the GNF1M Mouse tissue
atlas (Su, et al. (2004) Proc. Natl. Acad. Sci. USA 101, 6062-6067).
Detailed conditions of the cell and tissue preparation and
treatment are available in the above study. Normalised gene
expression level data for each tissue and cell type are shown.
(PDF)
Figure S13 Labeling of A33 in Peyer’s patches of wild-
type and A33-/- mice. Immunofluorescence analysis of Peyer’s
patches shows A33 antigen (red) at the FAE and villus epithelium
of the wild-type (A) mouse, but not in the A33-/- mouse (B). Two
separate Peyer’s patches of wt and A33-/- mice were analyzed.
The LAMP1 label (green) shows the location of FAE and SED. (C)
Quantification of the A33 immunogold labeling density in electron
micrographs of Peyer’s patches of wild-type and A33-/- mice. The
total number of protein A–gold (PAG) particles were counted on
100 mm2 of germinal centres from 2 mice and then averaged.
Equal areas were counted in control sections that were exposed to
PAG only and the A33 antibody was omitted. Scale bar in (A) and
(B): 25 mm.
(PDF)
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